We are live on ! Find out more
UBS AM

UBS AM Portfolio holdings

AUM $481B
1-Year Est. Return 26.39%
 

UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.

This Fund
S&P 500
This Quarter Est. Return
+0.41%
1 Year Est. Return
+26.39%
3 Year Est. Return
+93.76%
5 Year Est. Return
+124.47%
10 Year Est. Return
+503.87%
AUM
$241B
AUM Growth
+$7.57B
Cap. Flow
+$8.13B
Cap. Flow %
3.37%
Top 10 Hldgs %
21.84%
Holding
2,809
New
56
Increased
1,358
Reduced
887
Closed
62

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$948M
2
SNOW icon
Snowflake
SNOW
+$542M
3
SE icon
Sea Limited
SE
+$501M
4
PG icon
Procter & Gamble
PG
+$491M
5
SNAP icon
Snap
SNAP
+$403M

Sector Composition

Rank Sector Weight
1 Technology 26.21%
2 Healthcare 13.25%
3 Financials 13.07%
4 Consumer Discretionary 12.28%
5 Communication Services 10.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IBRX icon
2501
ImmunityBio
IBRX
$7.15B
$420K ﹤0.01%
43,139
+17,217
+66% +$189K
TBRG
2502
DELISTED
TruBridge
TBRG
$420K ﹤0.01%
11,849
-1,966
-14% -$66.7K
BCEL
2503
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$419K ﹤0.01%
67,312
+18,418
+38% +$123K
MRSN
2504
DELISTED
Mersana Therapeutics
MRSN
$409K ﹤0.01%
1,737
BBSI icon
2505
Barrett Business Services
BBSI
$1.01B
$408K ﹤0.01%
21,400
+4,000
+23% +$74.8K
KNSA icon
2506
Kiniksa Pharmaceuticals
KNSA
$6.31B
$404K ﹤0.01%
+35,490
New +$462K
SPRU icon
2507
Spruce Power Holding Corp
SPRU
$36.6M
$404K ﹤0.01%
8,191
LXRX icon
2508
Lexicon Pharmaceuticals
LXRX
$1.03B
$403K ﹤0.01%
83,874
+7,499
+10% +$30.8K
ESPR
2509
DELISTED
Esperion Therapeutics
ESPR
$403K ﹤0.01%
33,476
HIMS icon
2510
Hims & Hers Health
HIMS
$5.79B
$403K ﹤0.01%
53,420
+4,159
+8% +$35.2K
TCS
2511
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
$402K ﹤0.01%
2,817
+534
+23% +$89.5K
ABST
2512
DELISTED
Absolute Software Corp
ABST
$402K ﹤0.01%
36,600
UMC icon
2513
United Microelectronic
UMC
$42.9B
$400K ﹤0.01%
35,000
-3,700
-10% -$39.7K
GAN
2514
DELISTED
GAN Ltd
GAN
$399K ﹤0.01%
26,805
+5,405
+25% +$86.5K
ORLA
2515
Orla Mining
ORLA
$3.36B
$397K ﹤0.01%
120,400
CTRN icon
2516
Citi Trends
CTRN
$555M
$397K ﹤0.01%
5,435
+2,232
+70% +$179K
DX
2517
Dynex Capital
DX
$3.18B
$396K ﹤0.01%
22,932
-11,838
-34% -$209K
TUR icon
2518
iShares MSCI Turkey ETF
TUR
$201M
$395K ﹤0.01%
18,601
-5,363
-22% -$119K
VFF icon
2519
Village Farms International
VFF
$239M
$394K ﹤0.01%
47,220
+3,920
+9% +$36.6K
SDC
2520
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
$391K ﹤0.01%
73,493
+7,445
+11% +$46.2K
LOCO icon
2521
El Pollo Loco
LOCO
$503M
$390K ﹤0.01%
23,101
+2,720
+13% +$49.1K
SPNS
2522
DELISTED
Sapiens International
SPNS
$380K ﹤0.01%
13,207
GERN icon
2523
Geron
GERN
$898M
$379K ﹤0.01%
276,819
MUX icon
2524
McEwen Inc
MUX
$1B
$378K ﹤0.01%
36,377
ADVM
2525
DELISTED
Adverum Biotechnologies
ADVM
$378K ﹤0.01%
17,398
+3,611
+26% +$92.2K

Similar funds

UBS AM's Q3 2021 Portfolio in Review

As of Q3 2021, UBS AM held 2,809 positions worth $241B, up 3.2% from $234B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

UBS AM deployed $8.13B of net new capital in Q3 2021, opening 56 new positions and adding to 1,358 existing holdings. Its largest new stake was State Street SPDR Portfolio Intermediate Term Treasury ETF: 6,053,315 shares worth $196M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Infosys, an estimated $434M trimmed.

  • UBS AM's largest Q3 2021 buy was State Street SPDR Portfolio Intermediate Term Treasury ETF: 6,053,315 shares worth $196M.
  • UBS AM added most to Microsoft in Q3 2021, an estimated $948M increase.
  • UBS AM's biggest Q3 2021 reduction was Infosys, cutting an estimated $434M.
  • UBS AM fully exited Vanguard Short-Term Treasury ETF in Q3 2021, selling an estimated $350M.
  • UBS AM's ten largest holdings make up 22% of its $241B portfolio in Q3 2021.
  • UBS AM opened 56 new positions and closed 62 in Q3 2021.
  • UBS AM's portfolio value rose 3.2% quarter-over-quarter to $241B.

Based on UBS AM's 13F filing for Q3 2021, filed 15 Nov 2021.